From: A surveillance system to assess the need for updating systematic reviews
CER title; first author last name (publication date) | Latest search date for CER (across databases) | Number of included studies in CER (total or per KQ) | Period covered by surveillance assessment search | Number of new studies judged as relevant for inclusion in CER |
---|---|---|---|---|
(Journal publication, if available) | Time between search and report release | Â | Time between original searches and update search | Â |
Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer; Wilt (February 2008) [22] | September 2007 | 436 | January 2007 to March 2012 | 21 |
(Systematic review: association Between Hospital and Surgeon Radical Prostatectomy Volume and Patient Outcomes: A Systematic Review) [35] | 5Â months | Â | 54Â months | Â |
Comparative Effectiveness of Medications to Reduce Risk of Primary Breast Cancer in Women; Nelson (September 2009) [11] | January 2009 | 13 (KQ1,KQ3) | January 2008 to July 2011 | 3 |
(Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer) [36] | 8Â months | 70 (KQ2,KQ3) | 31Â months | Â |
 |  | 24 (KQ4) |  |  |
 |  | 16 (KQ5) |  |  |
Comparative Effectiveness of Core Needle Biopsy and Open Surgical Biopsy for Diagnosis of Breast Lesions; Bruening (December 2009) [10] | September 2009 | 107 (KQ1-2) | January 2008 to September 2011 | 19 |
(Systematic review: comparative effectiveness of core-needle and open surgical biopsy to diagnose breast lesions) [37] | 3Â months | NA (KQ3) | 24Â months | Â |
Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis; Phung (October 2010) [12] | April 2010 | 26(KQ1-2, KQ4, KQ6-7); 50 (KQ3); 3(KQ5) | January 2010 to August 2011 | 16 |
(Systematic review: recombinant human growth hormone in the treatment of patients with cystic fibrosis) [38] | 6Â months | Â | 16Â months | Â |
Therapies for Children with Autism Spectrum Disorders; Warren (April 2011) [13] | May 2010 | 159 | January 2009 to October 2011 | 15 |
(Systematic review: a systematic review of early intensive intervention for autism spectrum disorders) [39] | 11Â months | Â | 17Â months | Â |
Comparative Effectiveness of Traumatic Brain Injury and Depression; | June 2010 | 115 | January 2010 to October 2011 | 29 |
Guillamondegui (April 2011) [15] | 10Â months | Â | 16Â months | Â |
Pain Management Interventions for Hip Fracture; Abou-Setta (May 2011) [14] | December 2010 | 98 | January 2008 to November 2011 | 1 |
(Systematic review: comparative effectiveness of pain management interventions for hip fracture: a systematic review) [40] | 5Â months | Â | 11Â months | Â |
Diagnosis and Treatment of Obstructive Sleep Apnea in Adults; Balk (August 2011) [27] | September 2010 | 44 (KQ1); 1 (KQ2); 2 (KQ3); 11 (KQ4); 173 (KQ5); 6 (KQ6); 18 (KQ7) | January 2010 to April 2012 | 35 |
(Systematic review: auto-titrating versus fixed continuous positive airway pressure for the treatment of obstructive sleep apnea: a systematic review with meta-analyses) [41] | 11Â months | Â | 19Â months | Â |
Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults; Gaynes (September 2011) [30] | 18 November 2010 | 64 | January 2010 to March 2012 | 9 |
 | 10 months |  | 16 months |  |
Attention Deficit Hyperactivity Disorder (ADHD): Effectiveness of Treatment in At-Risk Preschoolers; Long-term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment; Charach (October 2011) [33] | 31 May 2010 | 53 (KQ1); 76 (KQ2); NR (KQ3) | January 2010 to June 2012 | 17 |
 | 17 months |  | 25 months |  |
Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection; Butler (December 2011) [29] | June 2010 and for KQ3 May 2011 | 13 (KQ1); 36 (KQ2); 13 (KQ3); 40 (KQ4) | January 2010 to June 2012 | 7 |
(Systematic review: comparative effectiveness of Clostridium difficile treatments: a systematic review) [42] | 7 to 18Â months | Â | 24Â months for KQ 1,2, 4 | Â |
 |  |  | 13 months for KQ3 |  |
Noncyclic Chronic Pelvic Pain Therapies for Women: Comparative Effectiveness; Andrews (January 2012) [28] | May 2011 | 23 (KQ1); 7 (KQ2); 0 (KQ3); 17 (KQ4); 0 (KQ5) | May 2011 to July 2012 | 2 |
(Systematic review: systematic review of therapies for noncyclic chronic pelvic pain in women) [43] | 8Â months | Â | 14Â months | Â |
Chronic Kidney Disease Stages 1 to 3: Screening, Monitoring, and Treatment; | January 2011 | 110 | January 2011 to August 2012 | 20 |
Fink (January 2012) [31] | 12Â months | Â | 19Â months | Â |
(Systematic review: screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the US Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline) [44] | Â | Â | Â | Â |
First and second generation antipsychotics for children and young adults; Seida (February 2012) [32] | February 2011 | 81 | January 2011 to August 2012 | 19 |
(Systematic review: antipsychotics for children and young adults: a comparative effectiveness review) [45] | 12Â months | Â | 18Â months | Â |
Comparative Effectiveness of Management Strategies for Renal Artery Stenosis: 2007 Update; Balk (November 2007) [26] | 23 April 2007 | 8 | October 2006 to June 2012 | 7 |
 | 7 months |  | 62 months |  |
Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation; IP (July 2009) [18] | December 2008 | 120 | June 2008 to September 2011 | 33 |
(Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation) [46] | 7Â months | Â | 35Â months | Â |
Comparative Effectiveness of Lipid-Modifying Agents; Sharma (September 2009) [17] | May 2009 | 101 | November 2008 to October 2011 | 20 |
(Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia) [47] | 4Â months | Â | 29Â months | Â |
Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease; Coleman (October 2009) [20] | February 2009 | 60 | August 2008 to November 2011 | 12 |
(Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease) [48] | 8Â months | Â | 33Â months | Â |
Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications versus Usual Care; Yank (May 2010) [16] | August 2009 | 74 | February 2009 to January 2012 | 15 |
(Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications) [49] | 9Â months | Â | 29Â months | Â |
Comparative effectiveness and safety of radiotherapy treatments for head and neck cancer; Samson (May 2010) [19] | September 2009 | 108 | March 2009 to August 2011 | 7 |
 | 8 months |  | 23 months | 15 |
Comparative Effectiveness of Nonoperative and Operative Treatments for Rotator Cuff Tears; Sedia (July 2010) [21] | September 2009 | 137 | March 2009 to January 2012 | Â |
(Systematic review: nonoperative and operative treatments for rotator cuff tears) [50] | 10Â months | Â | 28Â months | Â |
Comparative Effectiveness of Terbutaline Pump for the Prevention of Preterm Birth; Gaudet (September 2011) [23] | April, 2011 | 14 | October 2010 to March 2012 | 0 |
(Systematic review: effectiveness of Terbutaline Pump for the Prevention of Preterm Birth. A Systematic Review and Meta-Analysis) [51] | 5Â months | Â | 11Â months | Â |
Self-Measured Blood Pressure Monitoring: Comparative Effectiveness; Uhlig (January 2012) [24] | 19 July 2011 | 48 (KQ1-2); 1( KQ5) | January 2011 to August 2012 | 1 |
 | 6 months | 0 (KQ 3–4) | 13 months |  |
Hematopoietic Stem-Cell Transplantation in the Pediatric Population; Ratko (February 2012) [25] | 17 August 2011 | 251 | February 2011 to September 2012 | 0 |
 | 6 months |  | 13 months |  |